Literature DB >> 15645192

[Pharmacogenetics: Important aspects for dermatology].

H F Merk1.   

Abstract

Pharmacogenetics, pharmacogenomics or metabonomics are terms reflecting a new trend in pharmacology taking into consideration individual factors which influence the effects of drugs. Examples in dermatology include glucose-6-phosphate dehydrogenase-polymorphism (DADPS), dihydropyrimidine dehydrogenase-deficiency (5-Fluoruracil), thiopurine-S-methyltransferase-deficiency (azathioprine), cytochrome P450 isoenzymes and transferases (drug allergy and allergic contact dermatitis), and intolerant reactions to NSAIDs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15645192     DOI: 10.1007/s00105-004-0878-1

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  3 in total

1.  Pharmacogenomics--drug disposition, drug targets, and side effects.

Authors:  William E Evans; Howard L McLeod
Journal:  N Engl J Med       Date:  2003-02-06       Impact factor: 91.245

Review 2.  Inheritance and drug response.

Authors:  Richard Weinshilboum
Journal:  N Engl J Med       Date:  2003-02-06       Impact factor: 91.245

3.  A slow acetylator genotype is a risk factor for sulphonamide-induced toxic epidermal necrolysis and Stevens-Johnson syndrome.

Authors:  P Wolkenstein; V Carrière; D Charue; S Bastuji-Garin; J Revuz; J C Roujeau; P Beaune; M Bagot
Journal:  Pharmacogenetics       Date:  1995-08
  3 in total
  1 in total

Review 1.  [Pharmacogenetics].

Authors:  H F Merk
Journal:  Hautarzt       Date:  2010-08       Impact factor: 0.751

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.